Inventor · disambiguated record
Christa C. Chrovian
Also filed as: CHROVIAN CHRISTA · CHROVIAN CHRISTA C
23 granted patents·5 pending applications·146 citations·filing 2009–2024
95Inventor score
Top patents by PatentIndex Score
28 records- 0196US9464084B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Oct 11, 2016·16 cites·6 claims
- 0295US9066946B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jun 30, 2015·20 cites·32 claims
- 0394US10150765B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted Dec 11, 2018·11 cites·18 claims
- 0494US10071988B2Substituted 1,2,3-triazoles as NR2B-selective NMDA modulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Sep 11, 2018·17 cites·22 claims
- 0594US9963447B2Substituted 4-azaindoles and their use as GluN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2016·Granted May 8, 2018·17 cites·26 claims
- 0693US10617676B2Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GluN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Apr 14, 2020·12 cites·27 claims
- 0793US10233173B2Substituted 1,2,3-triazoles as NR2B-selective NMDA modulatorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Mar 19, 2019·13 cites·20 claims
- 0892US11820770B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Nov 21, 2023·1 cites·20 claims
- 0992US10377753B2Substituted 4-azaindoles and their use as GluN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Aug 13, 2019·13 cites·31 claims
- 1091US10112937B2P2X7 modulators and methods of useJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Oct 30, 2018·11 cites·40 claims
- 1190US12247027B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2023·Granted Mar 11, 2025·0 cites·10 claims
- 1289US11530210B2Substituted heteroaromatic pyrazolo-pyridines and their use as GLUN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Dec 20, 2022·2 cites·129 claims
- 1389US11207298B2Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Dec 28, 2021·2 cites·32 claims
- 1486US11225478B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Jan 18, 2022·1 cites·46 claims
- 1585US10766880B2Substituted 1,2,3-triazoles as NR2B-selective NMDA modulatorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Sep 8, 2020·2 cites·27 claims
- 1683US10703749B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2018·Granted Jul 7, 2020·1 cites·6 claims
- 1781US2023338341A1SUBSTITUTED 1H-IMIDAZO[4,5-b]PYRIDIN-2(3H)-ONES AND THEIR USE AS GLUN2B RECEPTOR MODULATORSJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 1879US8357684B2Thyazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolaseJANSSEN PHARMACEUTICA NV·Filed 2011·Granted Jan 22, 2013·5 cites·21 claims
- 1977US2025136598A1Substituted pyrazolo-pyridine amides and their use as glun2b receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2024·Application pending·0 cites
- 2075US11759455B2Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Sep 19, 2023·0 cites·25 claims
- 2175US7939527B2Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolaseJANSSEN PHARMACEUTICA NV·Filed 2009·Granted May 10, 2011·2 cites·37 claims
- 2273US12172997B2Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Dec 24, 2024·0 cites·22 claims
- 2367US12338243B2P2X7 modulatorsJANSSEN PHARMACEUTICA NV·Filed 2022·Granted Jun 24, 2025·0 cites·23 claims
- 2467US2023045960A1Substituted heteroaromatic pyrazolo-pyridines and their use as glun2b receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 2558US2022274984A1Substituted heteroaromatic pyrazolo-pyridines and their use as glun2b receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2022·Application pending·0 cites
- 2654US11618750B2Substituted pyrazolo-pyridine amides and their use as GluN2B receptor modulatorsJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Apr 4, 2023·0 cites·124 claims
- 2739US2018118749A1P2x7 modulatorsJansssen Pharmaceutica NV·Filed 2015·Application pending·0 cites
- 2828US8399465B2Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene A4 hydrolaseBACANI GENESIS·Filed 2010·Granted Mar 19, 2013·0 cites·54 claims
Join the waitlist — get patent alerts
Get an alert when Christa C. Chrovian files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →